In the Copenhagen City Heart Study, which comprised 68 patients with type 1 diabetes and 323 patients with type 2 diabetes, pulmonary injury assessed through FEV1 and FVC was somewhat more pronounced in those treated with insulin in comparison with those treated with diet or oral agents [30]. This evidence concerns the gene INS and type 2 diabetes mellitus.